PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet

Diabetes

Volumn 53, Issue 8, 2004, Pages 1949-1952

  Van Den Hoek, Anita M ^a,b   Heijboer, Annemieke C ^a,b   Corssmit, Eleonora P M ^b   Voshol, Peter J ^a,b   Romijn, Johannes A ^b   Havekes, Louis M ^a,b   Pijl, Hanno ^b  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE Y; PEPTIDE YY; PEPTIDE YY[3-36]; PROOPIOMELANOCORTIN; UNCLASSIFIED DRUG; FATTY ACID; GLUCOSE; INSULIN; PEPTIDE YY (3 36); PEPTIDE YY (3-36);

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FATTY ACID TRANSPORT; FOOD INTAKE; GLUCOSE TRANSPORT; HYPOTHALAMUS; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BLOOD; C57BL MOUSE; DIET RESTRICTION; DRUG EFFECT; FAT INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; SKELETAL MUSCLE; TRANSPORT AT THE CELLULAR LEVEL;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; DIETARY FATS; FASTING; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; INJECTIONS, INTRAVENOUS; INSULIN; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PEPTIDE YY;

EID: 3242794268     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.8.1949     Document Type: Article

References (19)

1. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR: Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89:1070-1077, 1985
2. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, Reeve JR Jr: Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51:151-159, 1994
3. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR: Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650-654, 2002
4. Morley JE, Levine AS, Grace M, Kneip J: Peptide YY (PYY), a potent orexigenic agent. Brain Res 341:200-203, 1985
5. Hagan MM, Moss DE: Effect of peptide YY (PYY) on food-associated conflict. Physiol Behav 58:731-735, 1995
6. Challis BG, Pinnock SB, Coll AP, Carter RN, Dickson SL, O'Rahilly S: Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem Biophys Res Commun 311:915-919, 2003
7. Marks JL, Waite K: Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat. J Neuroendocrinol 9:99-103, 1997
8. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B: Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133:1753-1758, 1993
9. Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L: Central melanocortin receptors regulate insulin action. J Clin Invest 108:1079-1085, 2001
10. Voshol PJ, Jong MC, Dahlmans VE, Kratky D, Levak-Frank S, Zechner R, Romijn JA, Havekes LM: In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes 50:2585-2590, 2001
11. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Biophys 37:911-917, 1959
12. Rossetti L, Giaccari A: Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake: a dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest 85:1785-1792, 1990
13. Goudriaan JR, Dahlmans VE, Teusink B, Ouwens DM, Febbraio M, Maassen JA, Romijn JA, Havekes LM, Voshol PJ: CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J Lipid Res 44:2270-2277, 2003
14. Lee HM, Udupi V, Englander EW, Rajaraman S, Coffey RJ Jr, Greeley GH Jr: Stimulatory actions of insulin-like growth factor-I and transforming growth factor-alpha on intestinal neurotensin and peptide YY. Endocrinology 140:4065-4069, 1999
15. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR: Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349:941-948, 2003
16. Parker E, Van Heek M, Stamford A: Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status. Eur J Pharmacol 440:173-187, 2002
17. Sainsbury A, Rohner-Jeanrenaud F, Cusin I, Zakrzewska KE, Halban PA, Gaillard RC, Jeanrenaud B: Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia 40:1269-1277, 1997
18. Sainsbury A, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B: Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats. Diabetes 46:209-214, 1997
19. Makimura H, Mizuno TM, Roberts J, Silverstein J, Beasley J, Mobbs CV: Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice. Diabetes 49:1917-1923, 2000